AI Content Chat (Beta) logo

Journal of Medicinal Chemistry pubs.acs.org/jmc Article (26) Pitto, M.; Chigorno, V.; Renlund, M.; Tettamanti, G. Oxide Substituted γ-Amino Acids and Hybrid Peptides. Org. Biomol. Impairment of Ganglioside Metabolism in Cultured Fibroblasts Chem. 2014, 12, 8462−8472. from Salla Patients. Clin. Chim. Acta 1996, 247, 143−157. (45) Vasko, R. C.; Rodriguez, R. A.; Cunningham, C. N.; Ardi, V. C.; (27) Aula, N.; Jalanko, A.; Aula, P.; Peltonen, L. Unraveling the Agard, D. A.; McAlpine, S. R. Mechanistic Studies of Sansalvamide A- Molecular Pathogenesis of Free Sialic Acid Storage Disorders: Altered Amide: An Allosteric Modulator of Hsp90. ACS Med. Chem. Lett. Targeting of Mutant Sialin. Mol. Genet. Metab. 2002, 77,99−107. 2010, 1,4−8. ́ (28) Biancheri, R.; Rossi, A.; Verbeek, H. A.; Schot, R.; Corsolini, F.; (46) Sagne, C.; Agulhon, C.; Ravassard, P.; Darmon, M.; Hamon, Assereto, S.; Mancini, G. M. S.; Verheijen, F. W.; Minetti, C.; M.; El Mestikawy, S.; Gasnier, B.; Giros, B. Identification and Filocamo, M. Homozygosity for the p.K136E Mutation in the Characterization of a Lysosomal Transporter for Small Neutral Amino SLC17A5 Gene as Cause of an Italian Severe Salla Disease. Acids. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 7206−7211. Neurogenetics 2005, 6, 195−199. (47) Kalatzis, V.; Cherqui, S.; Antignac, C.; Gasnier, B. Cystinosin, + (29) Thompson, C. M.; Davis, E.; Carrigan, C. N.; Cox, H. D.; the Protein Defective in Cystinosis, Is a H -Driven Lysosomal Cystine Bridges, R. J.; Gerdes, J. M. Inhibitor of the Glutamate Vesicular Transporter. EMBO J. 2001, 20, 5940−5949. Transporter (VGLUT). Curr. Med. Chem. 2005, 12, 2041−2056. (48) Bizzarri, R.; Arcangeli, C.; Arosio, D.; Ricci, F.; Faraci, P.; (30) Pietrancosta, N.; Kessler, A.; Favre-Besse, F.-C.; Triballeau, N.; Cardarelli, F.; Beltram, F. Development of a Novel GFP-Based Quentin, T.; Giros, B.; El Mestikawy, S.; Acher, F. C. Rose Bengal Ratiometric Excitation and Emission PH Indicator for Intracellular Analogs and Vesicular Glutamate Transporters (VGLUTs). Bioorg. Studies. Biophys. J. 2006, 90, 3300−3314. Med. Chem. 2010, 18, 6922−6933. (49) Yan, N. Structural Biology of the Major Facilitator Superfamily (31) Tamura, Y.; Ogita, K.; Ueda, T. A New VGLUT-Specific Transporters. Annu. Rev. Biophys. 2015, 44, 257−283. Potent Inhibitor: Pharmacophore of Brilliant Yellow. Neurochem. Res. (50) Drew, D.; Boudker, O. Shared Molecular Mechanisms of 2014, 39, 117−128. Membrane Transporters. Annu. Rev. Biochem. 2016, 85, 543−572. (32) Moriyama, Y.; Nomura, M. Clodronate: A Vesicular ATP (51) Leano, J. B.; Batarni, S.; Eriksen, J.; Juge, N.; Pak, J. E.; Kimura- Release Blocker. Trends Pharmacol. Sci. 2018, 39,13−23. Someya, T.; Robles-Colmenares, Y.; Moriyama, Y.; Stroud, R. M.; ́ Edwards, R. H. Structures Suggest a Mechanism for Energy Coupling (33) Pietrancosta, N.; Anne, C.; Prescher, H.; Ruivo, R.; Sagne, C.; by a Family of Organic Anion Transporters. PLoS Biol. 2019, 17, Debacker, C.; Bertrand, H.-O.; Brossmer, R.; Acher, F.; Gasnier, B. No. e3000260. Successful Prediction of Substrate-Binding Pocket in SLC17 Trans- (52) Mancini, G. M.; Beerens, C. E.; Aula, P. P.; Verheijen, F. W. porter Sialin. J. Biol. Chem. 2012, 287, 11489−11497. Sialic Acid Storage Diseases: A Multiple Lysosomal Transport Defect (34) Huang, Y.; Lemieux, M. J.; Song, J.; Auer, M.; Wang, D.-N. for Acidic Monosaccharides. J. Clin. Invest. 1991, 87, 1329−1335. Structure and Mechanism of the Glycerol-3-Phosphate Transporter (53) Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. from Escherichia Coli. Science 2003, 301, 616−620. Development and Validation of a Genetic Algorithm for Flexible (35) Irwin, J. J.; Shoichet, B. K. ZINC - A Free Database of Docking. J. Mol. Biol. 1997, 267, 727−748. Commercially Available Compounds for Virtual Screening. J. Chem. (54) Kleta, R.; Aughton, D. J.; Rivkin, M. J.; Huizing, M.; Strovel, E.; Inf. Model. 2005, 45, 177−182. Anikster, Y.; Orvisky, E.; Natowicz, M.; Krasnewich, D.; Gahl, W. A. (36) Jawalekar, A. M.; Meeuwenoord, N.; Cremers, J. S. G. O.; Biochemical and Molecular Analyses of Infantile Free Sialic Acid Overkleeft, H. S.; Van Der Marel, G. A.; Rutjes, F. P. J. T.; Van Delft, Storage Disease in North American Children. Am. J. Med. Genet. F. L. Conjugation of Nucleosides and Oligonucleotides by [3+2] 2003, 120A,28−33. Cycloaddition. J. Org. Chem. 2008, 73, 287−290. (55) Robichaud, T.; Appleyard, A. N.; Herbert, R. B.; Henderson, P. (37) Lin, W.; Long, L.; Feng, J.; Wang, B.; Guo, C. Synthesis of J. F.; Carruthers, A. Determinants of Ligand Binding Affinity and Meso-Coumarin-Conjugated Porphyrins and Investigation of Their Cooperativity at the GLUT1 Endofacial Site. Biochemistry 2011, 50, Luminescence Properties. Eur. J. Org. Chem. 2007, 2007, 4301−4304. 3137−3148. (38) Shibu, E. S.; Ono, K.; Sugino, S.; Nishioka, A.; Yasuda, A.; (56) Blat, Y. Non-Competitive Inhibition by Active Site Binders. Shigeri, Y.; Wakida, S. I.; Sawada, M.; Biju, V. Photouncaging Chem. Biol. Drug Des. 2010, 75, 535−540. Nanoparticles for MRI and Fluorescence Imaging in Vitro and in ̈̈ Vivo. ACS Nano 2013, 7, 9851−9859. (57) Morello, J.-P.; Bouvier, M.; Petaja-Repo, U. E.; Bichet, D. G. (39) Wirtz, L.; Kazmaier, U. A Mild Titanium-Catalyzed Synthesis Pharmacological Chaperones: A New Twist on Receptor Folding. of Functionalized Amino Coumarins as Fluorescence Labels. Eur. J. Trends Pharmacol. Sci. 2000, 21, 466−469. Org. Chem. 2011, 2011, 7062−7065. (58) Parenti, G.; Andria, G.; Valenzano, K. J. Pharmacological (40) Kim, J. H.; Sumranjit, J.; Kang, H. J.; Chung, S. J. Discovery of Chaperone Therapy: Preclinical Development, Clinical Translation, Coumarin Derivatives as Fluorescence Acceptors for Intrinsic and Prospects for the Treatment of Lysosomal Storage Disorders. Fluorescence Resonance Energy Transfer of Proteins. Mol. BioSyst. Mol. Ther. 2015, 23, 1138−1148. 2014, 10,30−33. (59) The Uniprot Consortium. UniProt: A Worldwide Hub of ̌ ̈ Protein Knowledge. Nucleic Acids Res. 2019, 47, D506−D515. (41) Sebej, P.; Wintner, J.; Muller, P.; Slanina, T.; Al Anshori, J.; (60) Thompson, J. D.; Higgins, D. G.; Gibson, T. J. CLUSTAL W: ́ Antony, L. A. P.; Klan, P.; Wirz, J. Fluorescein Analogues as Improving the Sensitivity of Progressive Multiple Sequence Alignment Photoremovable Protecting Groups Absorbing at ∼520 nm. J. Org. through Sequence Weighting, Position-Specific Gap Penalties and Chem. 2013, 78, 1833−1843. Weight Matrix Choice. Nucleic Acids Res. 1994, 22, 4673−4680. (42) Montalbetti, C. A. G. N.; Falque, V. Amide Bond Formation ̌ and Peptide Coupling. Tetrahedron 2005, 61, 10827−10852. (61) Sali, A.; Blundell, T. L. Comparative Protein Modelling by Satisfaction of Spatial Restraints. J. Mol. Biol. 1993, 234, 779−815. (43) Rudolf, K.; Eberlein, W.; Engel, W.; Pieper, H.; Entzeroth, M.; (62) Jo, S.; Kim, T.; Iyer, V. G.; Im, W. CHARMM-GUI: A Web- Hallermayer, G.; Doods, H. Development of Human Calcitonin Based Graphical User Interface for CHARMM. J. Comput. Chem. Gene-Related Peptide (CGRP) Receptor Antagonists. 1. Potent and 2008, 29, 1859−1865. 2-[3,5-Dibromo-N- Selective Small Molecule CGRP Antagonists. 1-[N (63) Schindelin, J.; Arganda-Carreras, I.; Frise, E.; Kaynig, V.; [[4-(3,4-Dihydro-2(1H)-Oxoquinazolin-3-Yl)-1-Piperidinyl]- Longair, M.; Pietzsch, T.; Preibisch, S.; Rueden, C.; Saalfeld, S.; Carbonyl]-D-Tyrosyl]-l-Lysyl]-4-(4-Pyridinyl)piperazine: The First Schmid, B.; Tinevez, J.-Y.; White, D. J.; Hartenstein, V.; Eliceiri, K.; CGRP Antagonist for Clinical Trials in Acute Migraine. J. Med. Tomancak, P.; Cardona, A. Fiji: An Open-Source Platform for Chem. 2005, 48, 5921−5931. Biological-Image Analysis. Nat. Methods 2012, 9, 676−682. (44) Mali, S. M.; Ganesh Kumar, M.; Katariya, M. M.; Gopi, H. N. (64) Baumann, A.-M. T.; Bakkers, M. J. G.; Buettner, F. F. R.; HBTU Mediated 1-Hydroxybenzotriazole (HOBt) Conjugate Addi- Hartmann, M.; Grove, M.; Langereis, M. A.; De Groot, R. J.; tion: Synthesis and Stereochemical Analysis of β-Benzotriazole N- ̈ Muhlenhoff, M. 9-O-Acetylation of Sialic Acids Is Catalysed by 8248 https://dx.doi.org/10.1021/acs.jmedchem.9b02119 J. Med. Chem. 2020, 63, 8231−8249

Amino Acids Bearing Aromatic or Heteroaromatic Substituents as a New Class of Ligands for the Lysosomal Sialic Acid Transporter Sialin - Page 18 Amino Acids Bearing Aromatic or Heteroaromatic Substituents as a New Class of Ligands for the Lysosomal Sialic Acid Transporter Sialin Page 17 Page 19